1887

Abstract

is an emerging multidrug-resistant pathogen and very little information is available regarding its imipenem resistance in Latin American countries such as Bolivia. This study investigated the antimicrobial resistance profile of 46 clinical strains from different hospitals in Cochabamba, Bolivia, from March 2008 to July 2009, and the presence of carbapenemases as a mechanism of resistance to imipenem. Isolates were obtained from 46 patients (one isolate per patient; 30 males,16 females) with an age range of 1 day to 84 years, and were collected from different sample types, the majority from respiratory tract infections (17) and wounds (13). Resistance to imipenem was detected in 15 isolates collected from different hospitals of the city. These isolates grouped into the same genotype, named A, and were resistant to all antibiotics tested including imipenem, with susceptibility only to colistin. Experiments to detect carbapenemases revealed the presence of the OXA-58 carbapenemase. Further analysis revealed the location of the gene on a 40 kb plasmid. To our knowledge, this is the first report of carbapenem resistance in isolates from Bolivia that is conferred by the OXA-58 carbapenemase. The presence of this gene in a multidrug-resistant clone and its location within a plasmid is of great concern with regard to the spread of carbapenem-resistant in the hospital environment in Bolivia.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.032722-0
2012-01-01
2019-09-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/1/80.html?itemId=/content/journal/jmm/10.1099/jmm.0.032722-0&mimeType=html&fmt=ahah

References

  1. Bertini A., Giordano A., Varesi P., Villa L., Mancini C., Carattoli A.. ( 2006;). First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy. . Antimicrob Agents Chemother 50:, 2268–2269. [CrossRef][PubMed]
    [Google Scholar]
  2. Canduela M. J., Gallego L., Sevillano E., Valderrey C., Calvo F., Pérez J.. ( 2006;). Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections. . J Antimicrob Chemother 57:, 1220–1222. [CrossRef][PubMed]
    [Google Scholar]
  3. Celenza G., Pellegrini C., Caccamo M., Segatore B., Amicosante G., Perilli M.. ( 2006;). Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals. . J Antimicrob Chemother 57:, 975–978. [CrossRef][PubMed]
    [Google Scholar]
  4. CLSI ( 2007;). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 7th edn; Approved Standard. M7-A7. . Wayne, PA, USA:: Clinical and Laboratory Standards Institute;.
  5. Coelho J., Woodford N., Afzal-Shah M., Livermore D.. ( 2006;). Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. . Antimicrob Agents Chemother 50:, 756–758. [CrossRef][PubMed]
    [Google Scholar]
  6. Gallego L., Towner K. J.. ( 2001;). Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. . J Med Microbiol 50:, 71–77.[PubMed]
    [Google Scholar]
  7. Héritier C., Dubouix A., Poirel L., Marty N., Nordmann P.. ( 2005;). A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. . J Antimicrob Chemother 55:, 115–118. [CrossRef][PubMed]
    [Google Scholar]
  8. Higgins P. G., Poirel L., Lehmann M., Nordmann P., Seifert H.. ( 2009;). OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. . Antimicrob Agents Chemother 53:, 5035–5038. [CrossRef][PubMed]
    [Google Scholar]
  9. Higgins P. G., Dammhayn C., Hackel M., Seifert H.. ( 2010a;). Global spread of carbapenem-resistant Acinetobacter baumannii. . J Antimicrob Chemother 65:, 233–238. [CrossRef][PubMed]
    [Google Scholar]
  10. Higgins P. G., Lehmann M., Seifert H.. ( 2010b;). Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. . Int J Antimicrob Agents 35:, 305. [CrossRef][PubMed]
    [Google Scholar]
  11. Higgins P. G., Lehmann M., Wisplinghoff H., Seifert H.. ( 2010c;). gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. . J Clin Microbiol 48:, 4592–4594. [CrossRef][PubMed]
    [Google Scholar]
  12. Kulah C., Mooij M. J., Comert F., Aktas E., Celebi G., Ozlu N., Rijnsburger M. C., Savelkoul P. H. M.. ( 2010;). Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey. . Int J Antimicrob Agents 36:, 114–118. [CrossRef][PubMed]
    [Google Scholar]
  13. Lee K., Lim Y. S., Yong D., Yum J. H., Chong Y.. ( 2003;). Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. . J Clin Microbiol 41:, 4623–4629. [CrossRef][PubMed]
    [Google Scholar]
  14. Marqué S., Poirel L., Héritier C., Brisse S., Blasco M. D., Filip R., Coman G., Naas T., Nordmann P.. ( 2005;). Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. . J Clin Microbiol 43:, 4885–4888. [CrossRef][PubMed]
    [Google Scholar]
  15. McCracken M., DeCorby M., Fuller J., Loo V., Hoban D. J., Zhanel G. G., Mulvey M. R.. ( 2009;). Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007. . J Antimicrob Chemother 64:, 552–555. [CrossRef][PubMed]
    [Google Scholar]
  16. Mendes R. E., Bell J. M., Turnidge J. D., Castanheira M., Jones R. N.. ( 2009;). Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. . J Antimicrob Chemother 63:, 55–59. [CrossRef][PubMed]
    [Google Scholar]
  17. Papa A., Koulourida V., Souliou E.. ( 2009;). Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a newly established Greek hospital. . Microb Drug Resist 15:, 257–260. [CrossRef][PubMed]
    [Google Scholar]
  18. Poirel L., Marqué S., Héritier C., Segonds C., Chabanon G., Nordmann P.. ( 2005;). OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. . Antimicrob Agents Chemother 49:, 202–208. [CrossRef][PubMed]
    [Google Scholar]
  19. Poirel L., Naas T., Nordmann P.. ( 2010;). Diversity, epidemiology, and genetics of class D β-lactamases. . Antimicrob Agents Chemother 54:, 24–38. [CrossRef][PubMed]
    [Google Scholar]
  20. Queenan A. M., Bush K.. ( 2007;). Carbapenemases: the versatile β-lactamases. . Clin Microbiol Rev 20:, 440–458. [CrossRef][PubMed]
    [Google Scholar]
  21. Robledo I. E., Aquino E. E., Santé M. I., Santana J. L., Otero D. M., León C. F., Vázquez G. J.. ( 2010;). Detection of KPC in Acinetobacter spp. in Puerto Rico. . Antimicrob Agents Chemother 54:, 1354–1357. [CrossRef][PubMed]
    [Google Scholar]
  22. Rossi F., García P., Ronzon B., Curcio D., Dowzicky M. J.. ( 2008;). Rates of antimicrobial resistance in Latin America (2004–2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. . Braz J Infect Dis 12:, 405–415. [CrossRef][PubMed]
    [Google Scholar]
  23. Sader H. S., Jones R. N., Gales A. C., Silva J. B., Pignatari A. C..SENTRY Participants Group (Latin America) ( 2004;). SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. . Braz J Infect Dis 8:, 25–79. [CrossRef][PubMed]
    [Google Scholar]
  24. Sader H. S., Castanheira M., Mendes R. E., Toleman M., Walsh T. R., Jones R. N.. ( 2005;). Dissemination and diversity of metallo-β-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. . Int J Antimicrob Agents 25:, 57–61. [CrossRef][PubMed]
    [Google Scholar]
  25. Sambrook J., Russell D. W.. ( 2001;). Molecular Cloning: a Laboratory Manual, , 3rd edn.. Cold Spring Harbor, NY:: Cold Spring Harbor Laboratory;.
    [Google Scholar]
  26. Sevillano E., Gallego L., García-Lobo J. M.. ( 2009;). First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. . Pathol Biol (Paris) 57:, 493–495. [CrossRef][PubMed]
    [Google Scholar]
  27. Sgambatti S., Gales A. C., Sader H. S.. ( 2010;). Antimicrobial resistance in Gram-negative bacteria from developing countries. . In Antimicrobial Resistance in Developing Countries, pp. 249–266. Edited by De J Sosa A., Byarugaba D. K., Amábile-Cuevas C. F., Hsueh P. R., Kariuki S., Okeke I. N... New York, Dordrecht, Heidelberg, London:: Springer;.
    [Google Scholar]
  28. Souli M., Galani I., Giamarellou H.. ( 2008;). Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. . Euro Surveill 13:, 1–11.[PubMed]
    [Google Scholar]
  29. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B.. ( 1995;). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. . J Clin Microbiol 33:, 2233–2239.[PubMed]
    [Google Scholar]
  30. Tognim M. C. B., Andrade S. S., Silbert S., Gales A. C., Jones R. N., Sader H. S.. ( 2004;). Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. . Int J Infect Dis 8:, 284–291. [CrossRef][PubMed]
    [Google Scholar]
  31. Turton J. F., Kaufmann M. E., Warner M., Coelho J., Dijkshoorn L., van der Reijden T., Pitt T. L.. ( 2004;). A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. . J Hosp Infect 58:, 170–179. [CrossRef][PubMed]
    [Google Scholar]
  32. Walsh T. R.. ( 2010;). Emerging carbapenemases: a global perspective. . Int J Antimicrob Agents 36: (Suppl. 3), S8–S14. [CrossRef][PubMed]
    [Google Scholar]
  33. Wang H., Guo P., Sun H., Wang H., Yang Q., Chen M., Xu Y., Zhu Y.. ( 2007;). Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. . Antimicrob Agents Chemother 51:, 4022–4028. [CrossRef][PubMed]
    [Google Scholar]
  34. Woodford N., Ellington M. J., Coelho J. M., Turton J. F., Ward M. E., Brown S., Amyes S. G., Livermore D. M.. ( 2006;). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. . Int J Antimicrob Agents 27:, 351–353. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.032722-0
Loading
/content/journal/jmm/10.1099/jmm.0.032722-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error